Ignite Creation Date:
2024-05-06 @ 7:44 PM
Last Modification Date:
2024-10-26 @ 3:13 PM
Study NCT ID:
NCT06119217
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2023-09-22
Brief Title:
Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC Patients
Sponsor:
Trishula Therapeutics Inc
Organization:
Trishula Therapeutics Inc
Organization Data
Organization:
Trishula Therapeutics Inc
Class:
INDUSTRY
Study ID:
TTX-030-003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Trishula Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| AbbVie | INDUSTRY |